Sign in to continue:

Wednesday, January 28th, 2026
SGX corporate News

IX Biopharma Ltd Annual General Meeting 2025: Resolutions Passed, Director Re-Appointments, and Shareholder Updates

Posted on November 17, 2025 at 8:24 pm (GMT+8)

147
Views
Share on Facebook
Share on Twitter
  • Director Re-Appointments:
    • Mr. Albert Ho Shing Tung and Mr. Teo Woon Keng John were re-appointed as directors under retirement by rotation, with overwhelming 99.92% approval. Their continuity can provide stability in governance and strategic direction.
  • Directors’ Fees for FY2026: Approval was given for directors’ fees up to S\$334,000 for the year ending 30 June 2026, to be paid quarterly in arrears.
    Investor Note: No opposition to remuneration could indicate shareholder satisfaction with current board performance and compensation.
  • Re-Appointment of Auditors: Messrs BDO LLP was re-appointed as the Company’s auditors, with the board authorised to fix their remuneration. This ensures continuity in audit oversight, a key factor for investor confidence.
  • Share Issuance Authority:
    • The board received authority to allot and issue shares up to 100% of issued share capital, with up to 50% on a non pro-rata basis, subject to SGX-ST regulations.
      Potential Price Sensitivity: This broad mandate gives the board flexibility for capital raising, mergers, or acquisitions, which could materially affect share dilution and market perception.
  • Employee Incentive Schemes:
    • Approval for the issuance of shares under the iX Employee Share Option Scheme and iX Performance Share Plan, with a cap at 15% of total issued shares (excluding treasury shares and subsidiary holdings).
      Investor Note: The ability to issue shares for employee incentives may impact future share supply and potentially dilute existing holdings. However, such plans are typically used to align employee interests with shareholder value creation.

    • View IX BiopharmaW260718 Historical chart here



    Related Posts

    SGX corporate News

    Credit Bureau Asia Limited (TCU) – AGM Questions on Licensing, Operations, and Governance
    minichart
    April 12, 2025

    Credit Bureau Asia Limited Faces Shareholder Queries Over Licensing, Business Operations, and Governance Credit Bureau Asia Limited (TCU) is set to address shareholder concerns over its licensing, business operations, and governance at its upcoming...

    SGX corporate News

    Ascent Bridge Limited Announces Update on Utilisation of S$2.37 Million Placement Proceeds for Working Capital Needs
    minichart
    August 28, 2025

    Ascent Bridge Limited Updates Shareholders on Placement Proceeds Utilisation – What Does It Mean for Your Shares? Ascent Bridge Limited Updates Shareholders on Placement Proceeds Utilisation – What Does It Mean for Your Shares?...

    SGX corporate News

    Trendlines Group Receives SGX Approval for Placement of 83.68 Million New Shares at S$0.067 Each 1
    minichart
    January 14, 2026

    Details and Implications for Shareholders Potential Dilution: The placement of 83,680,000 new shares could significantly increase the company’s share float, potentially diluting the holdings of existing shareholders. This is a key consideration for investors,...